Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Non-cash Items (2018 - 2025)

Historic Non-cash Items for Aytu Biopharma (AYTU) over the last 10 years, with Q4 2025 value amounting to $138042.0.

  • Aytu Biopharma's Non-cash Items rose 6958.68% to $138042.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $138042.0, marking a year-over-year increase of 6958.68%. This contributed to the annual value of $100000.0 for FY2025, which is 5000.0% down from last year.
  • As of Q4 2025, Aytu Biopharma's Non-cash Items stood at $138042.0, which was up 6958.68% from $100000.0 recorded in Q3 2025.
  • Aytu Biopharma's 5-year Non-cash Items high stood at $400000.0 for Q2 2021, and its period low was $2664.0 during Q4 2022.
  • For the 5-year period, Aytu Biopharma's Non-cash Items averaged around $110069.0, with its median value being $90699.5 (2022).
  • Its Non-cash Items has fluctuated over the past 5 years, first soared by 437577.49% in 2021, then plummeted by 9854.0% in 2023.
  • Aytu Biopharma's Non-cash Items (Quarter) stood at $47838.0 in 2021, then plummeted by 94.43% to $2664.0 in 2022, then surged by 668.39% to $20470.0 in 2023, then soared by 297.65% to $81399.0 in 2024, then surged by 69.59% to $138042.0 in 2025.
  • Its last three reported values are $138042.0 in Q4 2025, $100000.0 for Q3 2025, and $100000.0 during Q2 2025.